Disclosures for "Monoclonal Humanized One-Armed Antibody Blocking Therapy for Anti-NMDAR Encephalitis")
-
Dr. Matsumoto has received personal compensation for serving as an employee of Arialys Therapeutics, Inc.. Dr. Matsumoto has received personal compensation for serving as an employee of Astellas Pharma Inc.. Dr. Matsumoto has stock in Arialys Therapeutics, Inc.. Dr. Matsumoto has received intellectual property interests from a discovery or technology relating to health care. Dr. Matsumoto has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Yamaki has received personal compensation for serving as an employee of Arialys. Dr. Yamaki has received personal compensation for serving as an employee of Astellas. Dr. Yamaki has received intellectual property interests from a discovery or technology relating to health care.
-
Mrs. Kazimi has received personal compensation for serving as an employee of Arialys Therapeutics. Mrs. Kazimi has received personal compensation for serving as an employee of BPS Bioscience.
-
Mr. Kanno has received personal compensation for serving as an employee of Astellas Pharma Inc,. Mr. Kanno has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arialys. Mr. Kanno has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Maeda has received personal compensation for serving as an employee of Astellas Pharma Inc.. Dr. Maeda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arialys Therapeytic Inc.. Dr. Maeda has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Kubo has received personal compensation for serving as an employee of Astellas Pharma Inc.. Dr. Kubo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arialys Therapeutics Inc.. Dr. Kubo has received intellectual property interests from a discovery or technology relating to health care.
-
Mr. Mitchell has received personal compensation for serving as an employee of Arialys Therapeutics.
-
Dr. Lichter has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Janux.